Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the ad-inserter domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/n9v8e4u0p3/domains/zeetechnical.com/public_html/wp-includes/functions.php on line 6131

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the digital-newspaper domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/n9v8e4u0p3/domains/zeetechnical.com/public_html/wp-includes/functions.php on line 6131
Aurobindo Pharma Archives » ZEE TECHNICAL Aurobindo Pharma Archives » ZEE TECHNICAL
December 10, 2025

ZEE TECHNICAL

Quality Tech Articles & Tips

Tag: Aurobindo Pharma

photo

Aurobindo in-licenced chemotherapy induced neutropenia drug Ryzneuta gets USFDA nod, sends scrip soaring to 52-week high – Times of India

05 mins

[ad_1] HYDERABAD: Pharma major Aurobindo Pharma on Wednesday informed the bourses that the US Food & Drug Administration (USFDA) has approved Ryzneuta (Efbemalenograstim alfa injection), a novel long-acting Granulocyte colony-stimulating factor (G-CSF) for the treatment of chemotherapy-Induced Neutropenia (CIN) in cancer patients, that it in-licenced from biopharma player Evive Biotech.News of the US regulatory nod…

Read More